Video

Dr. Shinohara on Radiation Therapy Considerations in Prostate Cancer

Eric Shinohara, MD, MSCI, discusses radiation therapy considerations for patients with prostate cancer.

Eric Shinohara, MD, MSCI, associate professor and interim chair, Vanderbilt University Medical Center, discusses radiation therapy considerations for patients with prostate cancer.

When considering the types of radiation therapy options available for patients with prostate cancer, other health conditions and urinary function are often considered. Often times, other forms of radiation can be longer, taking 5 weeks or 9 weeks, and sometimes that can affect a patient's urination function a bit more. When speaking with a patient about the different types of radiation they could potentially receive, comorbidities and urinary function are factored into the decision, as well as the size of their prostate gland, concludes Shinohara.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD